Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection

Nemoto, Kenji; Takai, Kenji; Ogawa, Yoshihiro; Sakayauchi, Toru; Sugawara, Toshiyuki; Jingu, K.; Wada, Hitoshi; Takai, Yoshihiro; Yamada, Satoshi

doi:10.1016/j.ijrobp.2005.05.011

Cited by 6 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The current ablative techniques used include photodynamic therapy, argon plasma coagulation, esophagectomy, and laser treatment. Radiation therapy has been reported to be useful in such cases [17]. Katada et al [4] reported 33 cases of local recurrence after an EMR, and 31 cases were treated by EMR again; the remaining 2 patients had chemoradiotherapy.…”

Section: Discussionmentioning

confidence: 99%

Argon plasma coagulation for local recurrence of squamous cell carcinoma of the esophagus after endoscopic mucosal resection: technique and outcome

et al. 2008

View full text Add to dashboard Cite

Background. It is diffi cult to undergo a second endoscopic mucosal resection (EMR) for local cancer recurrence because ulcer scars caused by the previous EMR are frequently located near the tumor. The main objective of this study was to evaluate whether argon plasma coagulation (APC) is an effective and safe modality for treating early esophageal cancer recurrence untreatable by EMR. Methods. We reviewed the experience of this clinic in the administration of EMR for the treatment of mucosal esophageal cancer in 249 patients with 276 lesions (142, m1; 98, m2; 36, m3)

show abstract

Section: Discussionmentioning

confidence: 99%

Argon plasma coagulation for local recurrence of squamous cell carcinoma of the esophagus after endoscopic mucosal resection: technique and outcome

et al. 2008

View full text Add to dashboard Cite

show abstract

“…이러한 결과는 조기 편평세 포암종 식도암 환자에서 내시경 점막 절제술 후 잔여 병변이 남아 있는 경우 보조적인 화학방사선요법이 국소 재발을 방지 하는 데 유용함을 시사한다. 7 (2) 근치 치료 내시경 점막 절제술을 시행하기 어려운 표재성 식도암은 원 칙적으로 수술을 시행한다. 이러한 경우 5년 생존율은 40~80% 정도이다.…”

Section: 본 론unclassified

Chemoradiotherapy for Esophageal Cancer

Park¹

2019

Korean J Helicobacter Up Gastrointest Res

View full text Add to dashboard Cite

Esophageal cancer is a highly lethal malignancy. Squamous cell cancer (SCC) and adenocarcinoma are two major histologic types of esophageal cancer. The therapeutic approaches for both histologic types tend to be similar. Endoscopic therapy is considered in patients with Tis and T1a, and surgery alone is recommended in patients with T1N0 esophageal SCC or adenocarcinoma. Definitive chemoradiotherapy is a reasonable option for patients unable to withstand surgery. Esophagectomy is considered as the initial treatment for patients with clinical T2N0 esophageal SCC and those with adenocarcinoma with low lymph node metastasis risk. Combined modality therapy is recommended for patients with T3N0, T4aN0, and clinically node-positive thoracic esophageal cancer, regardless of histology. Definitive concurrent chemoradiotherapy is the most appropriate treatment approach for patients with esophageal SCC who are not surgical candidates. Definitive concurrent chemoradiotherapy is also considered for esophageal SCC patients who are potential surgical candidates with an endoscopically documented complete response after neoadjuvant chemoradiotherapy. For chemoradiotherapy non-responders, surgery is recommended for those who remain operable after chemoradiotherapy. Esophagectomy is also recommended for patients with esophageal adenocarcinoma after neoadjuvant chemoradiotherapy. Definitive concurrent chemoradiotherapy is preferred over surgery in patients with cervical esophageal cancer because its survival rate is similar to that of surgery and major morbidity can be avoided. Concurrent chemoradiotherapy rather than radiation therapy alone is recommended for patients who can tolerate this approach for non-metastatic, inoperable, or unresectable esophageal SCC or adenocarcinoma.

show abstract

Tumors of the Esophagus

Das¹

2010

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

View full text Add to dashboard Cite

Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection

Cited by 6 publications

References 19 publications

Argon plasma coagulation for local recurrence of squamous cell carcinoma of the esophagus after endoscopic mucosal resection: technique and outcome

Argon plasma coagulation for local recurrence of squamous cell carcinoma of the esophagus after endoscopic mucosal resection: technique and outcome

Chemoradiotherapy for Esophageal Cancer

Tumors of the Esophagus

Contact Info

Product

Resources

About